Free tool
FAERS Monitor: Quiofic
Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations
Reports naming NDA 216395 or its brand name (Quiofic, Folic Acid). Reports on generic versions are filed under their own applications.
Reports
250,981
Serious
186,221
74% of reports
Hospitalization
91,151
Death reported
23,615
Any cause; not necessarily from the drug
Most reported reactions
MedDRA preferred terms.
- drug ineffective25,501
- fatigue24,215
- pain23,889
- arthralgia20,192
- off label use18,427
- rheumatoid arthritis18,093
- nausea16,256
- diarrhoea14,829
- headache14,796
- rash14,199
- dyspnoea13,866
- abdominal discomfort12,119
- alopecia12,024
- joint swelling11,899
- condition aggravated11,648
Reports by year received
View as table
| Year | Reports |
|---|---|
| 2004 | 4,028 |
| 2005 | 3,947 |
| 2006 | 3,047 |
| 2007 | 3,025 |
| 2008 | 3,897 |
| 2009 | 5,191 |
| 2010 | 5,881 |
| 2011 | 7,320 |
| 2012 | 10,346 |
| 2013 | 11,131 |
| 2014 | 11,991 |
| 2015 | 14,840 |
| 2016 | 16,506 |
| 2017 | 14,724 |
| 2018 | 15,635 |
| 2019 | 16,226 |
| 2020 | 18,152 |
| 2021 | 16,635 |
| 2022 | 16,696 |
| 2023 | 14,171 |
| 2024 | 14,802 |
| 2025 | 13,764 |
| 2026 | 9,022 |
Disproportionality screen
Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 20,803,178 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.
| Reaction | Reports | PRR | 95% CI lower | Chi-squared |
|---|---|---|---|---|
| rheumatoid arthritisSignal | 18,093 | 15.7 | 15.5 | 210,427 |
| joint swellingSignal | 11,899 | 9.1 | 8.9 | 77,291 |
| abdominal discomfortSignal | 12,119 | 6.4 | 6.3 | 52,164 |
| alopeciaSignal | 12,024 | 5.4 | 5.3 | 40,850 |
| arthralgiaSignal | 20,192 | 4.2 | 4.2 | 48,269 |
| painSignal | 23,889 | 3.4 | 3.3 | 38,996 |
| condition aggravatedSignal | 11,648 | 3.3 | 3.2 | 18,204 |
| rashSignal | 14,199 | 2.8 | 2.7 | 16,083 |
| fatigueSignal | 24,215 | 2.7 | 2.6 | 25,197 |
| dyspnoeaSignal | 13,866 | 2.1 | 2.0 | 7,784 |
| headacheSignal | 14,796 | 2.0 | 2.0 | 7,459 |
| diarrhoea | 14,829 | 1.9 | 1.9 | 6,883 |
| off label use | 18,427 | 1.8 | 1.8 | 6,432 |
| nausea | 16,256 | 1.7 | 1.7 | 5,166 |
| drug ineffective | 25,501 | 1.6 | 1.6 | 6,559 |
A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.